Clinical Trial Update: Omegaven as Alternative Parenteral Fat Nutrition [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Omegaven as an alternative parenteral fat nutrition for cholestasis conditions; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholestasis
• Cholestasis of Parenteral Nutrition

Drugs mentioned

• Omegaven (fish oil-based intravenous fat emulsion)

Snippet

Sponsor: University of South Florida | Conditions: Cholestasis, Cholestasis of Parenteral Nutrition | Phase 3 | Status: COMPLETED | Results posted: 2020-07-22